What happened at our AGM and Members’ Meeting 2025?

Joint Neuroscience Council President, Mr Riki Trivedi and Neurological Alliance CEO, Georgina Carr welcomed attendees to the day.  The Joint Neurosciences Council and the Neurological Alliance took place in parallel.

View slides from the day here.

Keynote : Ashley Dalton MP, Parliamentary Under-Secretary of State for Public Health and Prevention

The Minister:

  • Reaffirmed government support for the UK Neuro Forum.
  • Acknowledged the need to tackle unwarranted variation in neurological care, workforce shortages, and inequities in cross-border care.
  • Emphasized the need to involve people with lived experience of neurological conditions and use their knowledge to make real changes for the people on the ground.
  • Confirmed the government’s commitment to accelerating innovation by reducing bureaucracy, investing in clinical trial infrastructure, and strengthening collaboration across NHS, academic institutions, industry and the  voluntary sector.
  • Acknowledged the alliance’s call for a modern service framework in neurology.
  • Pledged her commitment to a transparent selection process,  although was unable to say which conditions would be prioritized in the next tranche of modern service frameworks.
  • Thanked attendees for their commitment to improving workforce and services for people affected by neurological conditions.

Involving people with lived experience in 2024/25

Paul and Ginny outline their experience of being involved in our work this year.

Trustee elections

We extend a warm welcome to trustees newly elected to the board and trustees returning to the board for a second term.

Alex Massey (Head of Campaigning, Policy and Public Affairs,  Motor Neurone Disease Association) and Sue  Millman (CEO, Ataxia UK) were elected to the Board of Trustees.

Rob Music (CEO, The  Migraine Trust) and Victoria Wareham (Director of Operations and Development, Dystonia UK) were re-elected to the Board of Trustees.

Panel discussions: AI and workforce

Panel discussions explored the potential impact of AI on the neuroscience workforce and on current services for people affected by neurological conditions.

  • There are many promising examples of AI being used to deliver consistent care, speed up administrative tasks in hospital settings, enable better outcomes in surgery and cancer screening, and potentially reduce the amount of time needed to train clinical staff.
  • Action is needed to put robust and effective systems in place to deliver care, and significant system change is needed to achieve this.
  • AI alone will not solve the fundamental problems of workforce shortages, inequitable care and a lack of services for people affected by neurological conditions.

Annual report and accounts

Treasurer Kripen Dhondra gave a review of the financial year. The accounts for the year 2024/2025 were approved.

Our annual report and accounts are available to download here.

Save the date: AGM 2026

The next AGM will take place on 18 November 2026. Please contact us at info@neural.org.uk for details of how to register.